Having been a shareholder since the stock listed I have seen these spikes in sales and price regularly over the years......and while the volumes are a bit higher than the formative years, they are really not large. As much as I believe that GSS is still very much under valued......I don't imagine a lot will change until FDA approval comes through......and we can only hope that happens sooner rather than later and it results in some big players showing real interest.
News: GSS Genetic Signatures Expects Sales Of At Least A$21M For Half Year, page-29
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
71.0¢ |
Change
-0.015(2.07%) |
Mkt cap ! $152.8M | |||
| Open | High | Low | Value | Volume |
| 71.5¢ | 71.5¢ | 70.5¢ | $84.90K | 119.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 36217 | 70.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 73.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.51pm 05/07/2024 (20 minute delay) ? |
| GSS (ASX) Chart |